Akava Therapeutics

Winnetka, United States

Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.

$7.3M raised

Dec 2024

Grant

Health Care Medical Therapeutics

Top Investors

National Institute on Aging

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Akava Therapeutics

How much funding has Akava Therapeutics raised?

Akava Therapeutics has raised $7.3M in total funding. The most recent round was Grant. The last funding was announced in December 2024.

Who are Akava Therapeutics's investors?

Akava Therapeutics's investors include National Institute on Aging.

Where is Akava Therapeutics headquartered?

Akava Therapeutics is headquartered in Winnetka, United States.

What does Akava Therapeutics do?

Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.

What stage is Akava Therapeutics at?

Akava Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2024.

MLA

"Akava Therapeutics — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/akava-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2024). Akava Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/akava-therapeutics

Wikipedia (cite web)

{{cite web |title=Akava Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/akava-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2024.

Similar Companies in Health Care

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K